-
Amgen and Astellas Pharma US agree to settlement costs for kickback charges
europeanpharmaceuticalreview
May 05, 2019
Amgen and Astellas Pharma US have agreed to pay a total of $124.75 million to settle allegations that they paid kickbacks to Medicare copays for their own medications.
-
Pharmaceutical company and its former executives charged for drug trafficking
europeanpharmaceuticalreview
April 28, 2019
Pharmaceutical company and its former executives charged for drug trafficking.
-
Sharp invests $21M to expand US packaging capacity and capabilities
cphi-online
April 26, 2019
New equipment installations will include vial labellers, as well as an HPV cold sterilization system.
-
Sharp Expands US Operations
contractpharma
April 26, 2019
Sharp has invested $21 million in expanding capacity and capabilities at its Allentown and Conshohocken Pennsylvania facilities.
-
AbbVie, Boehringer Ingelheim's IL-23 inhibitor Skyrizi gains US approval for plaque psoriasis
firstwordpharma
April 25, 2019
AbbVie announced that the FDA approved Skyrizi (risankizumab-rzaa) for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.
-
Drug prices come under fire as US pharma lobby nears spending records
drugs
April 25, 2019
More ambitious changes may be needed to lower pharmaceutical prices as the Trump administration proposes new rules and approves a slew of new generic drugs.
-
Bayer invests in Khloris’ anti-cancer vaccines programme
pharmaceutical-technology
April 23, 2019
Bayer invests in Khloris’ anti-cancer vaccines programme.
-
Sanofi to slash costs of certain insulin products in US
pharmaceutical-technology
April 23, 2019
Sanofi to slash costs of certain insulin products in US
-
Developing the production of the radioisotope Tc-99m within the US
europeanpharmaceuticalreview
April 16, 2019
A team of university researchers have collaborated together to develop a method to produce the radioisotope Tc-99m in the US to prevent having to import it…
-
Suven gets US court's approval to buy assets of Rising Pharmaceuticals
firstwordpharma
April 15, 2019
Suven Life Sciences said it has received approval from a US bankruptcy court to buy assets of Rising ……
ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight June 2024: Globalization on the Go
